Approvals/TGA/COMIRNATY ORIGINAL/OMICRON BA.4-5 (tozinameran/famtozinameran) COVID-19 VACCINE 1.5/1.5 micrograms/0.2 mL concentrated suspension for injection vial

Approved

STANDARD

COMIRNATY ORIGINAL/OMICRON BA.4-5 (tozinameran/famtozinameran) COVID-19 VACCINE 1.5/1.5 micrograms/0.2 mL concentrated suspension for injection vial

Pfizer Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Date: May 30, 2025
Approval ID: 9783ffb144544b1c
Company: Pfizer Australia Pty Ltd
Type: Standard

Approval Details

Approval Id: 9783ffb144544b1c
Product Name: COMIRNATY ORIGINAL/OMICRON BA.4-5 (tozinameran/famtozinameran) COVID-19 VACCINE 1.5/1.5 micrograms/0.2 mL concentrated suspension for injection vial
Artg Id: 417266
Artg Name: COMIRNATY ORIGINAL/OMICRON BA.4-5 (tozinameran/famtozinameran) COVID-19 VACCINE 1.5/1.5 micrograms/0.2 mL concentrated suspension for injection vial
Sponsor: Pfizer Australia Pty Ltd
Company Detail Path: /organization/pfizer-australia-pty-ltd
Artg Date: 2024-05-14
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: REPI
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/87f72f1b7cf52abd018ed0370240b90b.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/67cddfe33876751fcdc6f8a06aea1ba4.pdf

Active Ingredients

Approved

Quick Info

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

9783ffb144544b1c

Type

Standard

Back to TGA Approvals